1 comment
46 forecasters
Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?
82%chance
The community sees this as a toss-up.
Forecast Timeline
No key factors yetAdd some that might influence this forecast.
Add key factor
Authors:
Opened:Nov 24, 2021
Closes:Dec 31, 2026
Scheduled resolution:Jan 1, 2027
Spot Scoring Time:Nov 26, 2021
Learn more about Metaculus NewsMatch
Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?
1% chance
55
Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?
67% chance
42
Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?
45% chance
27